Friday's Health Winners & Losers

Cerus (CERS Quote) was one of the best performers of Friday's session. After the previous close, the biotech company said it swung to a fourth-quarter profit that easily beat Wall Street's estimates. Cerus was recently up 33 cents, or 5.8%, to $6.07.

Telik (TELK Quote) was also higher after the company late Thursday posted a narrower-than-expected fourth-quarter loss. The stock was rising 38 cents, or 7%, to $5.85.

On the other hand, Gene Logic (GLGC Quote) slid 4.2% to $1.82 after the company said it may spin off its genomics division, which was once the company's core business.

PDL BioPharma (PDLI Quote) was also moving lower more than a day after the company missed fourth-quarter earnings targets. The stock was losing 26 cents, or 1.3%, to $19.45.

Among health care winners of the session, NeoPharm (NEOL Quote) surged 29.8% to $2.31. Celgene (CELG Quote) was adding 2.8% at $56.41. GlaxoSmithKline (GSK Quote) was higher by 1.1% to $57.

Among decliners, Forest Laboratories (FRX Quote) was off 1.2% at $54.34. Humana (HUM Quote) was losing 1.1% to $61.61. UnitedHealth Group (UNH Quote) was down 1% to $53.19.